Introduction
Patients demographics are shown in Table 1 . Thirty-eight patients with unilateral NTG were included. The mean age of the patients was 55.31 ± 11.13 years. There were no significant differences between the latanoprost group (affected eyes) and the control group (unaffected eyes) for baseline IOP and CCT. Mean CCT in both groups from baseline to the 24 months are shown in Table 2 . During follow up, mean CCT of latanoprost group was decreased except at 9 month after treatment, but only statistically significant after 24 months of treatment. (544.6 ± 38.4 vs. 540.3 ± 37.8㎛, p=0.013) There was no statistically significant change in CCT in the control group. (545.7 ± 33.7 vs. 545.3 ± 32.1㎛,
p=0.789)
We retrospectively reviewed the records of the all patients who were newly diagnosed unilateral NTG and medicated with latanoprost 0.005% monotherapy over 24 months. Unilateral NTG was defined as open angle detected by gonioscopy, an IOP consistently ≤ 21 mmHg, characteristic glaucomatous optic nerve head damage, such as notch and neuroretinal rim thinning in only one eye, glaucomatous visual field (VF) loss in only one eye, no neurologic disorder that could affect the optic nerve. Patients with ocular disease other than glaucoma, contact lens users and patients that had undergone refractive surgery, intraocular surgery or laser photocoagulation treatment were excluded. Also patients with myopia or hypermetropia greater than 3D or astigmatism more than 1D that could potentially affect our measurements were excluded. An unaffected eye in unilateral NTG patients was evaluated for the control group. The CCT was measured with an ultrasound pachymeter (AL-2000; Bio & Pachymeter) in upright position by the same physician. We obtained an average value from 5 consecutive measurements. CCT measurements before treatment and 3, 6, 9, 12 and 24 months after treatment were analyzed. To evaluate the variation in CCT values at different time intervals within the groups, a paired-sample ttest was used. An independent sample t-test was used to compare the baseline IOP, and baseline CCT between groups. A P value <0.05 was considered statistically significant. All the statistical analyses were carried out using SPSS 17.0 for Windows (SPSS Inc., Chicago,IL).
Results
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In this study, a statistically significant reduction in CCT was observed in latanoprost group at 24 month after treatment. In latanoprost group, the mean CCT was decreased during follow up period except at 9 month after treatment in spite of no statistically significant. Through retrospective chart review, we found that after 6 month of treatment, seventeen patients who had dry eye symptoms were prescribed the artificial tears consistently. That might be the reason why the mean CCT was not decreased at 9 month after treatment. Katadayi et al 5 showed that CCT in dry eyes increases rapidly and significantly compared to normal eyes after application of artificial tears. The predominant IOP effect of PG analogues is caused by MMP-1(matrix metalloproteinases-1) activation in the smooth muscle of the ciliary body. 6 Berfonzi et al 7 suggested that prolonged treatment with PG can induce collagen degradation in the stromal extracellular matrix owing to activation of MMPs and inhibition of tissue inhibitors of metalloproteinases (TIMPs). A long-lasting consequence could be the reduction of CCT.
Chronic exposure to a hyperosmotic tear film which is induced by topical anti-glaucoma medication, has been reported to induce corneal thinning. 8 Previous study which had a short-term follow up could not exclude the reason of CCT reduction due to dry eye caused by hyperosmotic tear film. However, in our study, the mean CCT was statistically significant decreased at 24 months after treatment even though the 17 patients applicated the artificial tears consistently after 6 months. This study could reconfirm that CCT reduction theory in prostaglandin analogs by MMPs activation. A Strength of this study was the inclusion of a group of unaffected eye of unilateral NTG patients as the control group, which can show that prostaglandin group and control had similar corneal parameter physiologically, thus demonstrating that the CCT reduction was due to the therapy. However, this was a retrospective study and small sample size. 
Conclusions
Purpose
This study was performed to evaluate the effect of latanoprost on the CCT in patients with unilateral NTG during 24 months follow-up periods.
Discussion
As influence of CCT on IOP measured by Goldmann applanation tonometer and thinner cornea in NTG than other glaucoma, it is important to determine CCT values serially during the follow-up, especially NTG patients who medicated prostaglandin analogs. Therefore, clinicians have to pay attention for proper IOP targeting.
